Kalaris Therapeutics (KLRS) Other Non-Current Assets (2021 - 2026)
Kalaris Therapeutics (KLRS) reported Other Non-Current Assets of $1.73 million for Q2 2026, up 150.2% from $691,000 a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Other Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics posted Other Non-Current Assets of $953,000, down 69.7% from FY2024.
- Other Non-Current Assets has a four-year compound annual growth rate of -3.6% (FY2021 to FY2025).
- By year, Other Non-Current Assets came in at $3.15 million in FY2024 (+269.2%), $852,000 in FY2023 (unchanged), $852,000 in FY2022 (-22.7%) and $1.1 million in FY2021.
- Five-year quarterly Other Non-Current Assets spans a low of $500,000 in Q1 2025 and a high of $3.15 million in Q4 2024.
- Year over year, Other Non-Current Assets gained in four of the last six quarters, with growth averaging 102.6%.
- The high point for year-over-year Other Non-Current Assets in five years was Q4 2024 (growth of 269.2%); the low point was Q4 2025 (a decline of 69.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.75 million (Q1 2026), $953,000 (Q4 2025) and $976,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - | 1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 953,000.00 |
| Sep 30, 2025 | 976,000.00 |
| Jun 30, 2025 | 691,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 3.15 Mn |
| Jun 30, 2024 | 554,000.00 |
| Mar 31, 2024 | 554,000.00 |
| Dec 31, 2023 | 852,000.00 |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 852,000.00 |
| Mar 31, 2023 | 852,000.00 |
| Dec 31, 2022 | 852,000.00 |
| Sep 30, 2022 | 852,000.00 |
| Jun 30, 2022 | 857,000.00 |
| Mar 31, 2022 | 979,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.21 Mn |
| Jun 30, 2021 | 692,000.00 |
API Access
Kalaris Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();